Literature DB >> 28285347

Endothelin-1 Induces Degeneration of Cultured Motor Neurons Through a Mechanism Mediated by Nitric Oxide and PI3K/Akt Pathway.

S D'Antoni1, E Ranno1, M Spatuzza1, S Cavallaro1, M V Catania2,3.   

Abstract

Endothelin-1 (ET-1) is a vasoactive peptide produced by activated astrocytes and microglia and is implicated in initiating and sustaining reactive gliosis in neurodegenerative diseases. We have previously suggested that ET-1 can play a role in the pathophysiology of amyotrophic lateral sclerosis (ALS). Indeed, we reported that this peptide is abundantly expressed in reactive astrocytes in the spinal cord of SOD1-G93A mice and ALS patients and exerts a toxic effect on motor neurons (MNs) in an in vitro model of mixed spinal cord cultures enriched with reactive astrocytes. Here, we explored the possible mechanisms underlying the toxic effect of ET-1 on cultured MNs. We show that ET-1 toxicity is not directly caused by oxidative stress or activation of cyclooxygenase-2 but requires the synthesis of nitric oxide and is mediated by a reduced activation of the phosphoinositide 3-kinase pathway. Furthermore, we observed that ET-1 is also toxic for microglia, although its effect on MNs is independent of the presence of this type of glial cells. Our study confirms that ET-1 may contribute to MN death and corroborates the view that the modulation of ET-1 signaling might be a therapeutic strategy to slow down MN degeneration in ALS.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Astrocytes; Endothelin; Motor neurons; Neurodegeneration; Nitric oxide

Mesh:

Substances:

Year:  2017        PMID: 28285347     DOI: 10.1007/s12640-017-9711-3

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  80 in total

1.  Estimation of Some Oxidative Stress Parameters and Blood Pressure After Administration of Endothelin-1 (ET-1) in Rats.

Authors:  Paulina Kleniewska; Agata Kowalczyk; Wlodzimierz Ciesla; Anna Goraca
Journal:  Cell Biochem Biophys       Date:  2015-04       Impact factor: 2.194

2.  Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures.

Authors:  E Galea; D L Feinstein; D J Reis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

3.  Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage response.

Authors:  Junghee Lee; Bela Kosaras; Hossein Aleyasin; Jeong A Han; David S Park; Rajiv R Ratan; Neil W Kowall; Robert J Ferrante; Sam W Lee; Hoon Ryu
Journal:  FASEB J       Date:  2006-09-28       Impact factor: 5.191

4.  Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis.

Authors:  L Speciale; M Sarasella; S Ruzzante; D Caputo; R Mancuso; M G Calvo; F R Guerini; P Ferrante
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

5.  Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo.

Authors:  M A Dwyer; D S Bredt; S H Snyder
Journal:  Biochem Biophys Res Commun       Date:  1991-05-15       Impact factor: 3.575

Review 6.  COX-2 and neurodegeneration in Parkinson's disease.

Authors:  P Teismann; M Vila; D-K Choi; K Tieu; D C Wu; V Jackson-Lewis; S Przedborski
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

Review 7.  Regulation of programmed cell death in neuronal cells by nitric oxide.

Authors:  Yun-Chul Kang; Peter K Kim; Byoung-Min Choi; Hun-Taeg Chung; Kwon-Soo Ha; Young-Guen Kwon; Young-Myeong Kim
Journal:  In Vivo       Date:  2004 May-Jun       Impact factor: 2.155

8.  Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes.

Authors:  Mostafa M Elgebaly; Vera Portik-Dobos; Kamakshi Sachidanandam; David Rychly; Daniel Malcom; Maribeth H Johnson; Adviye Ergul
Journal:  Vascul Pharmacol       Date:  2007-06-06       Impact factor: 5.773

9.  Over-expression of astrocytic ET-1 attenuates neuropathic pain by inhibition of ERK1/2 and Akt(s) via activation of ETA receptor.

Authors:  Victor K L Hung; Lydia W Tai; Qiu Qiu; Xin Luo; K L Wong; Sookja K Chung; C W Cheung
Journal:  Mol Cell Neurosci       Date:  2014-03-01       Impact factor: 4.314

10.  Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins.

Authors:  Alexandre Charbonneau; André Marette
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

View more
  12 in total

1.  The C9ORF72 Gene, Implicated in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, Encodes a Protein That Functions in Control of Endothelin and Glutamate Signaling.

Authors:  Vitalay Fomin; Patricia Richard; Mainul Hoque; Cynthia Li; Zhuoying Gu; Mercedes Fissore-O'Leary; Bin Tian; Carol Prives; James L Manley
Journal:  Mol Cell Biol       Date:  2018-10-29       Impact factor: 4.272

2.  Effect and Mechanism of Endothelin Receptor A Inhibitor BQ-123 Combined with Electroacupuncture on Tibia Cancer Pain in Rats.

Authors:  Jie Tang; Zhilu Sun; Yan Wang; Jing Liu; Shuai Wang; Xilian Wang
Journal:  Dis Markers       Date:  2022-05-17       Impact factor: 3.464

3.  Network Analysis Identifies Sex-Specific Gene Expression Changes in Blood of Amyotrophic Lateral Sclerosis Patients.

Authors:  Jose A Santiago; James P Quinn; Judith A Potashkin
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 4.  Implications of PI3K/AKT/PTEN Signaling on Superoxide Dismutases Expression and in the Pathogenesis of Alzheimer's Disease.

Authors:  Satoru Matsuda; Yukie Nakagawa; Ai Tsuji; Yasuko Kitagishi; Atsuko Nakanishi; Toshiyuki Murai
Journal:  Diseases       Date:  2018-04-20

5.  Involvement of Endothelin 1 in Remote Preconditioning-Induced Cardioprotection through connexin 43 and Akt/GSK-3β Signaling Pathway.

Authors:  Min Zhang; Wei Wei Gu; Xing Yu Hong
Journal:  Sci Rep       Date:  2018-07-19       Impact factor: 4.379

6.  Ulinastatin alleviates traumatic brain injury by reducing endothelin-1.

Authors:  Ting Liu; Xing-Zhi Liao; Mai-Tao Zhou
Journal:  Transl Neurosci       Date:  2021-01-07       Impact factor: 1.757

Review 7.  Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Authors:  Mehdi Ghasemi; Kiandokht Keyhanian; Catherine Douthwright
Journal:  Cells       Date:  2021-01-28       Impact factor: 6.600

8.  ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway.

Authors:  Hui Yin; Lunqing Wang; Fei Li; Dongfei Wang; Zhe Zhang; Bentong Yu; Yange Liu
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

9.  The Evidence for Sparsentan-Mediated Inhibition of INa and IK(erg): Possibly Unlinked to Its Antagonism of Angiotensin II or Endothelin Type a Receptor.

Authors:  Tzu-Hsien Chuang; Hsin-Yen Cho; Sheng-Nan Wu
Journal:  Biomedicines       Date:  2021-12-31

10.  The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations.

Authors:  Elena Grossini; Divya Garhwal; Sakthipriyan Venkatesan; Daniela Ferrante; Angelica Mele; Massimo Saraceno; Ada Scognamiglio; Jessica Mandrioli; Amedeo Amedei; Fabiola De Marchi; Letizia Mazzini
Journal:  Biomedicines       Date:  2022-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.